Wenqian Xu
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
PAK6 drives tumor microenvironment remodeling in nasopharyngeal carcinoma with lymph node necrosis: implications for distant metastasis and survival.
Journal: International immunopharmacology
Published: June 13, 2025
Pseudogene pair-based prognostic model reveals LAT as a biomarker of immune response in head and neck squamous cell carcinoma.
Journal: Discover oncology
Published: May 15, 2025
The key role of DLX6 in nasopharyngeal carcinoma: metastasis, angiogenesis and tumor immune mechanism.
Journal: Frontiers in immunology
Published: November 04, 2024
Inhibition of PNCK inflames tumor microenvironment and sensitizes head and neck squamous cell carcinoma to immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: September 26, 2024
Integrated multi-omics reveal lactate metabolism-related gene signatures and PYGL in predicting HNSCC prognosis and immunotherapy efficacy.
Journal: BMC cancer
Published: September 14, 2024
m6A methylation profiling as a prognostic marker in nasopharyngeal carcinoma: insights from MeRIP-Seq and RNA-Seq.
Journal: Frontiers in immunology
Published: September 07, 2024
Integrative single cell transcriptomic analysis reveals 3p deletion associated tumor microenvironment and chemoresistance in head and neck squamous cell carcinoma.
Journal: Scientific reports
Published: September 02, 2024
Identification and validation of a prognostic risk model based on radiosensitivity-related genes in nasopharyngeal carcinoma.
Journal: Translational oncology
Published: August 10, 2024
The causal impact of complement C3d receptor 2 on head and neck cancer microenvironment and its implications for immunotherapy response prediction.
Journal: Heliyon
Published: February 15, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026